Project Grant K23DK147855
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $350,902 Project Grant to the University of California, Irvine on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports a surgeon-scientist candidate's research and career development focused on investigating urethral dysfunction in female urinary incontinence (UI). The research addresses a significant...
- Federal Grant Award Summary Yale University received a $193,809 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025 through April 30, 2030. The award supports clinical research investigating the efficacy and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for treating acute cardio-renal syndrome (CRS), a condition where...
- Federal Grant Award Summary Yale University received a $1.33M Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period June 1, 2025 through May 31, 2029. The award funds basic biomedical research investigating the compensatory mechanisms by which pancreatic alpha-cells (A-cells) preserve insulin secretion and glycemic control in response to...
- Federal Project Grant Award Summary Yale University received a $802,843 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 13, 2025, with completion targeted for June 30, 2030. The research will investigate the pathogenic mechanisms linking obesity to cardiometabolic complications in pediatric populations, with specific focus on how...
- Federal Grant Award Summary Yale University received a $167,916 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period May 1, 2026 through April 30, 2028. The award supports research investigating genetic dysregulation of messenger ribonucleic acid (mRNA) translation in Type 1 Diabetes (T1D). The research project aims to advance understanding of how...
- Federal Project Grant Award Summary Yale University received a $172,622 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on June 17, 2025, with a completion date of January 31, 2029. The research project, conducted at Yale's New Haven, Connecticut facility, focuses on elucidating the role of cyclin G-associated kinase (GAK) as a regulator of...
- Federal Grant Award Summary Yale University received a $133,333 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 15, 2025 and completion date of August 31, 2026. The funded research aims to develop interventions to correct the myeloid bias of aged hematopoietic stem and progenitor cells (HSPCs) by preventing linker...
- Federal Grant Award Summary The University of Vermont received a $320,778 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through August 31, 2028. This research project investigates the intersection of pituitary adenylate cyclase-activating peptide (PACAP)/PAC1 receptor signaling and corticotropin-releasing hormone (CRH)...
- Federal Project Grant Award Summary The University of California, San Francisco received a $512,595 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 15, 2026, with completion targeted for February 28, 2030. This award funds basic biomedical research investigating a novel neural circuit mechanism that regulates urinary and fecal...
- Federal Grant Award Summary Baylor College of Medicine received a $152,300 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 1, 2026 through February 28, 2029. This research project investigates the impact of the diabetic urinary environment on Group B Streptococcus (GBS) virulence and host immune response. The research addresses the significantly...
Yale University received a $193,874 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through December 31, 2030. The award funds a patient-centered research initiative to improve treatment outcomes for urinary incontinence (UI) among women with comorbid obesity and type 2 diabetes mellitus (T2DM). The project delivers three primary research products: (1) evidence-based assessment of patient preferences for obtaining UI care in primary care settings through mixed-methods research involving surveys (n=100) and guided interviews (n=12-20); (2) design of a patient-centered collaborative care model (COCM) for UI utilizing participatory design methodology and the Integrated Promoting Action on Research Implementation in Health Services (IPARIHS) framework with stakeholder involvement; and (3) feasibility evaluation of the collaborative care model as delivered through the primary care setting. This research addresses a significant clinical and implementation gap, as only 15% of individuals with UI seek treatment despite evidence-based options being available. The project recognizes the bidirectional relationships between UI, obesity, and T2DM, where UI limits exercise critical for managing metabolic conditions while both conditions exacerbate UI severity. By combining treatment for these three diagnoses within a collaborative care model, the initiative aims to reduce healthcare burden, improve care access, and enhance treatment outcomes for affected populations while advancing the evidence base for implementing UI care in primary care settings.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $193.9k | 3/27/26 |